Authors:
MA LD
PENFORNIS A
WANG XL
SCHOENFELD D
AKERBLOM HK
TUOMILEHTO J
LOUNAMAA R
TOIVANEN L
FAGERLUND A
FLITTNER M
GUSTAFSSON B
HAGGQVIST C
HAKULINEN A
HERVA L
HILTUNEN P
HUHTAMAKI T
HUTTUNAN NP
HUUPPONEN T
HYTTINEN M
JOKI T
JOKISALO R
KAAR ML
KALLIO S
KAPRIO EA
KASKI U
KNIP M
LAINE L
LAPPALAINEN J
MAENPAA J
MAKELA AL
NIEMI K
NIIRANEN A
NUUJA A
OJAJARVI P
OTONKOSKI T
PIHLAJAMAKI K
PONTYNEN S
RAJANTIE J
SANKALA J
SCHUMACHER J
SILLANPAA M
STAHLBERG MR
STRAHLMANN CH
UOTILA T
VARE M
VARIMO P
WETTENSTRAND G
TUOMILEHTOWOLF E
METCALFE K
HITMAN G
FAUSTMAN D
Citation: Ld. Ma et al., EVALUATION OF TAP1 POLYMORPHISMS WITH INSULIN-DEPENDENT DIABETES-MELLITUS IN FINNISH DIABETIC-PATIENTS, Human immunology, 53(2), 1997, pp. 159-166
Authors:
TAMBUR AR
FOSTER P
MELLINS E
CRESSWELL P
FAUSTMAN D
GEBEL HM
Citation: Ar. Tambur et al., ULTRAVIOLET-B IRRADIATION REDUCES THE SURFACE EXPRESSION OF CONFORMATIONALLY CORRECT CLASS-I AND CLASS-II HISTOCOMPATIBILITY ANTIGENS, Transplantation proceedings, 29(6), 1997, pp. 2689-2691
Citation: A. Penfornis et al., EXAMINATION OF HUMAN BETA-2-MICROGLOBULIN (BETA-2-M) GENE AS A CONTRIBUTOR TO DEFECTIVE IDDM ANTIGEN PRESENTATION, Diabetologia, 40, 1997, pp. 211-211
Citation: Ja. Pinies et al., NEW MONOCLONAL-ANTIBODY DIAGNOSTIC REAGENTS FOR TYPE-I DIABETES - DIFFERENTIAL LYMPHOCYTE SURFACE-ANTIGEN EXPRESSION RELATED TO DISEASE, Diabetes, 46(3), 1997, pp. 363-371
Authors:
FAUSTMAN D
SHI LJ
MA LD
PENFORNIS A
YAN G
WANG XL
SCHOENFELD D
TUOMILEHTOWOLF E
METCALF K
HITMAN G
Citation: D. Faustman et al., IDENTIFICATION AND EVALUATION OF TAP1 POLYMORPHISMS WITH IDDM IN AMERICAN AND FINNISH DIABETIC-PATIENTS BY DGGE AND ARMS, Diabetes, 46, 1997, pp. 685-685
Citation: D. Faustman et al., NEW MONOCLONAL-ANTIBODY DIAGNOSTIC REAGENTS FOR TYPE-I DIABETES - DIFFERENTIAL LYMPHOCYTE SURFACE-ANTIGEN EXPRESSION RELATED TO DISEASE, Diabetes, 46, 1997, pp. 1322-1322
Authors:
LERNMARK A
EISENBARTH G
DUCAT L
ERLICH HA
FAUSTMAN D
MACLAREN NK
OTT J
PERMUTT MA
SHE JX
TODD J
Citation: A. Lernmark et al., FAMILY CELL-LINES AVAILABLE FOR RESEARCH - AN ENDANGERED RESOURCE, American journal of human genetics, 61(3), 1997, pp. 778-779
Citation: D. Faustman, STRATEGIES FOR CIRCUMVENTING TRANSPLANT REJECTION - MODIFICATION OF CELLS, TISSUES AND ORGANS, Trends in biotechnology, 13(3), 1995, pp. 100-105
Citation: F. Wang et al., IN-VITRO GENETIC THERAPY WITH TAP-1 OR TAP-2 RESTORES HLA CLASS-I PRESENTATION OF SELF-PEPTIDE IN IDDM B-CELLS, Diabetes, 44, 1995, pp. 17-17
Citation: D. Faustman et C. Coe, PREVENTION OF XENOGRAFT REJECTION BY MASKING DONOR HLA CLASS-I ANTIGENS, Journal of endocrinological investigation, 17(7), 1994, pp. 553-553
Citation: Fq. Li et al., ABNORMAL CLASS-I ASSEMBLY AND PEPTIDE PRESENTATION IN THE NONOBESE DIABETIC MOUSE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(23), 1994, pp. 11128-11132
Citation: Xp. Li et D. Faustman, USE OF DONOR BETA-2-MICROGLOBULIN-DEFICIENT TRANSGENIC MOUSE-LIVER CELLS FOR ISOGRAFTS, ALLOGRAFTS, AND XENOGRAFTS, Transplantation, 55(4), 1993, pp. 940-946